Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Emergent BioSolutions revenue
Emergent BioSolutions's revenue is $1.6 billion.
What is Emergent BioSolutions's revenue?
- Emergent BioSolutions's revenue growth from 2005 to 2020 is 1,090.16%.
- Emergent BioSolutions has 1,834 employees, and the revenue per employee ratio is $848,091.
- Emergent BioSolutions's peak quarterly revenue was $300.2M in 2024(q1).
- Emergent BioSolutions peak revenue was $1.6B in 2018.
- Emergent BioSolutions annual revenue for 2019 was 1.1B, -28.89% growth from 2018.
- Emergent BioSolutions annual revenue for 2020 was 1.6B, 40.63% growth from 2019.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Emergent BioSolutions historical revenue
Emergent BioSolutions's peak revenue was $1.6B in 2018. The peak quarterly revenue was $300.2M in 2024(q1).
Emergent BioSolutions's revenue increased from $130.7m in 2005 to $1.6B currently. That's a 1,090.16% change in annual revenue.
Emergent BioSolutions annual revenue
Emergent BioSolutions annual revenue over time
| Fiscal year / year | Emergent BioSolutions revenue |
|---|---|
| 2009 | $234.8M |
| 2010 | $286.2M |
| 2011 | $273.4M |
| 2012 | $281.9M |
| 2013 | $312.7M |
| 2014 | $404.5M |
| 2015 | $489.3M |
| 2016 | $488.8M |
| 2017 | $560.9M |
| 2018 | $1.6B |
| 2019 | $1.1B |
| 2020 | $1.6B |
Rate Emergent BioSolutions' financial transparency
Emergent BioSolutions annual growth
Emergent BioSolutions saw the greatest revenue growth in 2018, when revenue increased by 177.3%.
Emergent BioSolutions had the lowest revenue growth in 2022, when revenue changed by -37.47%.
Emergent BioSolutions annual growth rate over time
| Year | Emergent BioSolutions growth |
|---|---|
| 2009 | 31%↑ |
| 2010 | 22%↑ |
| 2011 | -4%↓ |
| 2012 | 3%↑ |
| 2013 | 11%↑ |
| 2014 | 29%↑ |
| 2015 | 21%↑ |
| 2016 | -0%↓ |
| 2017 | 15%↑ |
| 2018 | 177%↑ |
| 2019 | -29%↓ |
| 2020 | 41%↑ |
Emergent BioSolutions jobs nearby
Do you work at Emergent BioSolutions?
Did Emergent BioSolutions meet its revenue projections?
Emergent BioSolutions financial information
| CEO | Robert Kramer Sr. |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 1,834 |
| Date Founded | 1998 |
| Headquarters | Gaithersburg, Maryland |
| Number of Locations | 12 |
| Revenue | $1.6B |
| Net Income | -$223,800,000 |
| Gross Proft | $1.0B (2020) |
| EBITDA | $498.3M (2020) |
| PE Ratio | 10.46 |
| Tax Rate | 0.3% |
| Market Capitalization | $3.2B |
| Total Assets | $3,166,300,000 |
| Ticker | EBS |
Emergent BioSolutions jobs you might like
Emergent BioSolutions financing
Emergent BioSolutions received early financing of $2.0M on 2015-02-03.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Debt | $2M | 02/2015 |
| Grant | $20M | 09/2019 |
| Grant | $14.5M | 04/2020 |
Emergent BioSolutions investors
| Investors | Security type |
|---|---|
| Biomedical Advanced Research and Development Authority (BARDA) | Grant |
Emergent BioSolutions competitors
Emergent BioSolutions's top competitor, Merck, earned an annual revenue of $64.2B.
Emergent BioSolutions's smallest competitor is T2 Biosystems with revenue of $7.2M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 554 |
| Human Genome Sciences | $70,157 | $131.0M | 1,000 | - |
| Merck | $90,328 | $64.2B | 74,000 | 1,300 |
| Covance | $64,568 | $2.6B | 50,000 | - |
| Sarepta Therapeutics | $94,985 | $1.9B | 840 | 24 |
| Spectrum Pharmaceuticals | $84,494 | $10.1M | 235 | - |
| Medivation | $94,135 | $1.0B | 628 | - |
| Alnylam Pharmaceuticals | $81,014 | $2.2B | 1,323 | 1 |
| Pfizer | $70,868 | $63.6B | 78,500 | 323 |
| Cook Group | $47,314 | $2.0B | 12,000 | 63 |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Emergent BioSolutions highest paying jobs
Zippia gives an in-depth look into the details of Emergent BioSolutions, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Emergent BioSolutions. The employee data is based on information from people who have self-reported their past or current employments at Emergent BioSolutions. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Emergent BioSolutions. The data presented on this page does not represent the view of Emergent BioSolutions and its employees or that of Zippia.
Emergent BioSolutions may also be known as or be related to EMERGENT BIOSOLUTIONS INC., Emergent BioSolutions, Emergent BioSolutions Inc, Emergent BioSolutions Inc., Emergent BioSolutions, Inc. and Emergent Biosolutions.